1
|
Huang Y, Li J, Agarwal SK. Economic and Humanistic Burden of Rheumatoid Arthritis: Results From the US National Survey Data 2018-2020. ACR Open Rheumatol 2024. [PMID: 39105293 DOI: 10.1002/acr2.11728] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/03/2023] [Revised: 05/07/2024] [Accepted: 07/03/2024] [Indexed: 08/07/2024] Open
Abstract
OBJECTIVE Our objective was to estimate the economic and humanistic burden among US adults with rheumatoid arthritis (RA). METHODS This study analyzed results from the Medical Expenditure Panel Survey from 2018 to 2020. Adults (aged ≥18 years) self-reporting with RA or with the presence of the International Classification of Disease, 10th Revision clinical modification codes were identified. Healthcare expenditures (inpatient care, outpatient care, emergency department, office visits, prescription medications, home health, and others) were measured. The Short Form 12 Health Survey physical component summary (PCS), mental component summary (MCS), activities of daily living (ADL), and instrumental ADL (IADL) were measured. Two-part models assessed the incremental increase in the health care expenditures for the RA group compared to the non-RA group. In addition, the multivariable linear regression was used to evaluate the marginal difference in PCS and MCS between those with RA and those without RA, whereas the multivariable logistic regression models were used to evaluate the association between ADL and IADL by RA status. RESULTS Annually, 4.27 million adults with RA were identified. The two-part model showed significantly higher total annual healthcare expenditures in the RA group than non-RA group (mean $3,382.971 [95% confidence interval (CI) $1,816.50-$4,949.44]). Compared to the non-RA group, the RA group was associated with lower PCS scores (mean 4.78 [95% CI 3.47-6.09]) and similarly lower MCS scores (mean -0.84 [95% CI -2.18 to 0.50]), as well as increased odds of requesting ADL (adjusted odds ratio [aOR] 2.02 [95% CI 1.59-2.56]) and IADL assistance (aOR 2.11 [95% CI 1.57-2.84]). CONCLUSION RA was associated with higher health care expenditures, particularly prescription medication costs, and was associated with suboptimal quality of life.
Collapse
Affiliation(s)
- Yinan Huang
- School of Pharmacy, University of Mississippi, University, Mississippi
| | - Jieni Li
- College of Pharmacy, University of Houston, Houston, Texas
| | | |
Collapse
|
3
|
Quesque F, Nivet M, Etchepare A, Wauquiez G, Prouteau A, Desgranges B, Bertoux M. Social cognition in neuropsychology: A nationwide survey revealing current representations and practices. APPLIED NEUROPSYCHOLOGY. ADULT 2024; 31:689-702. [PMID: 35486070 DOI: 10.1080/23279095.2022.2061859] [Citation(s) in RCA: 3] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
Abstract
As a key domain of cognition, social cognition abilities are altered in a wide range of clinical groups. Accordingly, many clinical tests and theories of social cognition have been developed these last decades. Contrasting this abundant development from a research perspective, recent evidence suggests that social cognition remains rarely addressed from a clinial perspective. The aim of the present research was to characterize the current practices, representations, and needs linked to social cognition from the perspective of professional neuropsychologists and graduate students. A nationwide survey allowed us to determine the classical field conception of social cognition and its associated symptoms or notions. It also allowed us to quantify practice activities and the use of the different clinical tools available. This study revealed that neuropsychologists lack confidence regarding social cognition assessment and its rehabilitation, and that students are in demand for more knowledge and training. Suggestions of change in practices and dissemination of knowledge are discussed. Considering the importance of social cognition, an extension of initial and continuous training alongside an enrichment of interactions between researchers and clinicians were key recommendations to formulate, as well as the need for a consensual lexicon of current concepts.
Collapse
Affiliation(s)
- François Quesque
- Univ. Lille, Inserm, CHU Lille, U1172 - Lille Neuroscience & Cognition, LiCEND, DistALZ, Lille, France
- Centre National de Référence des Malformations et Maladies Congénitales du Cervelet, Département de Neurologie Pédiatrique, CHU de Lille, Lille, France
| | - Maxime Nivet
- Univ. Lille, Inserm, CHU Lille, U1172 - Lille Neuroscience & Cognition, LiCEND, DistALZ, Lille, France
| | - Aurore Etchepare
- Department of Adult Psychiatry, Hospital Center of Jonzac, Univ. Bordeaux, Bordeaux, France
| | - Grégoire Wauquiez
- Organisation Française des Psychologues spécialisés en Neuropsychologie, Paris, France
- Service de rééducation neurologique, CHU de Dijon, Dijon, France
| | - Antoinette Prouteau
- Department of Adult Psychiatry, Hospital Center of Jonzac, Univ. Bordeaux, Bordeaux, France
| | - Béatrice Desgranges
- Normandie Université, UNICAEN, PSL Université Paris, EPHE, Inserm, U1077, CHU de Caen, Neuropsychologie et Imagerie de la Mémoire Humaine, GIP Cyceron, Caen, France
| | - Maxime Bertoux
- Univ. Lille, Inserm, CHU Lille, U1172 - Lille Neuroscience & Cognition, LiCEND, DistALZ, Lille, France
| |
Collapse
|
6
|
Gwinnutt JM, Toyoda T, Barraclough M, Verstappen SMM, Hornberger M, MacGregor A. Cognitive impairment in the immune-mediated inflammatory diseases compared with age-matched controls: Systematic review and meta-regression. Semin Arthritis Rheum 2023; 58:152131. [PMID: 36527929 DOI: 10.1016/j.semarthrit.2022.152131] [Citation(s) in RCA: 3] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/30/2022] [Revised: 10/31/2022] [Accepted: 11/11/2022] [Indexed: 11/15/2022]
Abstract
OBJECTIVES To compare the magnitude of cognitive impairment against age-expected levels across the immune mediated inflammatory diseases (IMIDs: systemic lupus erythematosus [SLE], rheumatoid arthritis [RA], axial spondyloarthritis [axSpA], psoriatic arthritis [PsA], psoriasis [PsO]). METHODS A pre-defined search strategy was implemented in Medline, Embase and Psychinfo on 29/05/2021. Inclusion criteria were: (i) observational studies of an IMID, (ii) healthy control comparison, (iii) measuring cognitive ability (overall, memory, complex attention/executive function, language/verbal fluency), and (iv) sufficient data for meta-analysis. Standardised mean differences (SMD) in cognitive assessments between IMIDs and controls were pooled using random-effects meta-analysis. IMIDs were compared using meta-regression. RESULTS In total, 65 IMID groups were included (SLE: 39, RA: 19, axSpA: 1, PsA: 2 PsO: 4), comprising 3141 people with IMIDs and 9333 controls. People with IMIDs had impairments in overall cognition (SMD: -0.57 [95% CI -0.70, -0.43]), complex attention/executive function (SMD -0.57 [95% CI -0.69, -0.44]), memory (SMD -0.55 [95% CI -0.68, -0.43]) and language/verbal fluency (SMD -0.51 [95% CI -0.68, -0.34]). People with RA and people with SLE had similar magnitudes of cognitive impairment in relation to age-expected levels. People with neuropsychiatric SLE had larger impairment in overall cognition compared with RA. CONCLUSIONS People with IMIDs have moderate impairments across a range of cognitive domains. People with RA and SLE have similar magnitudes of impairment against their respective age-expected levels, calling for greater recognition of cognitive impairment in both conditions. To further understand cognition in the IMIDs, more large-scale, longitudinal studies are needed.
Collapse
Affiliation(s)
- James M Gwinnutt
- Centre for Epidemiology Versus Arthritis, Division of Musculoskeletal and Dermatological Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK.
| | - Task Toyoda
- Norwich Medical School, University of East Anglia, Norwich, UK
| | - Michelle Barraclough
- Centre for Epidemiology Versus Arthritis, Division of Musculoskeletal and Dermatological Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK; NIHR Manchester Biomedical Research Centre, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, UK; Schroeder Arthritis Institute, Krembil Research Institute, University Health Network, Toronto, Canada
| | - Suzanne M M Verstappen
- Centre for Epidemiology Versus Arthritis, Division of Musculoskeletal and Dermatological Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK; NIHR Manchester Biomedical Research Centre, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, UK
| | | | - Alex MacGregor
- Norwich Medical School, University of East Anglia, Norwich, UK; Rheumatology Department, Norfolk and Norwich University Hospitals NHS Trust, Norwich, UK
| |
Collapse
|
9
|
Quesque F, Coutrot A, Cox S, de Souza Leonardo C, Baez S, Cardona JF, Mulet-Perreault H, Flanagan E, Neely-Prado A, Clarens MF, Cassimiro L, Musa G, Kemp J, Botzung A, Philippi N, Cosseddu M, Trujillo C, Grisales JS, Fittipaldi S, Magrath Guimet N, Calandri IL, Crivelli L, Sedeno L, Garcia AM, Moreno F, Indakoetxea B, Benussi A, Brandão Moura MV, Santamaria-Garcia H, Matallana D, Prianishnikova G, Morozova A, Iakovleva O, Veryugina N, Levin O, Zhao L, Liang J, Duning T, Lebouvier T, Pasquier F, Huepe D, Barandiaran M, Johnen A, Lyashenko E, Allegri RF, Borroni B, Blanc F, Wang F, Yassuda MS, Lillo P, Teixeira AL, Caramelli P, Hudon C, Slachevsky A, Ibáñez A, Hornberger M, Bertoux M. Does culture shape our understanding of others' thoughts and emotions? An investigation across 12 countries. Neuropsychology 2022; 36:664-682. [PMID: 35834208 PMCID: PMC11186050 DOI: 10.1037/neu0000817] [Citation(s) in RCA: 17] [Impact Index Per Article: 8.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022] Open
Abstract
Measures of social cognition have now become central in neuropsychology, being essential for early and differential diagnoses, follow-up, and rehabilitation in a wide range of conditions. With the scientific world becoming increasingly interconnected, international neuropsychological and medical collaborations are burgeoning to tackle the global challenges that are mental health conditions. These initiatives commonly merge data across a diversity of populations and countries, while ignoring their specificity. OBJECTIVE In this context, we aimed to estimate the influence of participants' nationality on social cognition evaluation. This issue is of particular importance as most cognitive tasks are developed in highly specific contexts, not representative of that encountered by the world's population. METHOD Through a large international study across 18 sites, neuropsychologists assessed core aspects of social cognition in 587 participants from 12 countries using traditional and widely used tasks. RESULTS Age, gender, and education were found to impact measures of mentalizing and emotion recognition. After controlling for these factors, differences between countries accounted for more than 20% of the variance on both measures. Importantly, it was possible to isolate participants' nationality from potential translation issues, which classically constitute a major limitation. CONCLUSIONS Overall, these findings highlight the need for important methodological shifts to better represent social cognition in both fundamental research and clinical practice, especially within emerging international networks and consortia. (PsycInfo Database Record (c) 2022 APA, all rights reserved).
Collapse
Affiliation(s)
- François Quesque
- Univ. Lille, Inserm, CHU Lille, U1172 - LilNCog - Lille Neuroscience & Cognition, LiCEND, F-59000 Lille, France
| | | | - Sharon Cox
- Department of Behavioural Science and Health, Institute of Epidemiology and Healthcare, University College London, London, UK
| | | | | | | | | | - Emma Flanagan
- Norwich Medical School, University of East Anglia, UK
- Department of Clinical Neurosciences, University of Cambridge, UK
| | - Alejandra Neely-Prado
- Center for Social and Cognitive Neuroscience, School of Psychology, Adolfo Ibáñez University, Santiago, Chile
| | | | - Luciana Cassimiro
- School of Arts, Sciences and Humanities, University of São Paulo, Department of Neurology, São Paulo, Brazil
| | - Gada Musa
- Universidad de Chile, Santiago, Chile
| | | | | | | | | | | | | | - Sol Fittipaldi
- Universidad de San Andrés, Buenos Aires, Argentina
- National Scientific and Technical Research Council (CONICET), Argentina
| | | | | | - Lucia Crivelli
- FLENI Fondation, Department of Neurology, Buenos Aires, Argentina
| | - Lucas Sedeno
- National Scientific and Technical Research Council (CONICET), Argentina
| | - Adolfo M Garcia
- Universidad de San Andrés, Buenos Aires, Argentina
- National Scientific and Technical Research Council (CONICET), Argentina
- Departamento de Lingüística y Literatura, Facultad de Humanidades, Universidad de Santiago de Chile, Santiago, Chile
- Global Brain Health Institute (GBHI), University of California-San Francisco (UCSF), San Francisco, California, United States
| | - Fermin Moreno
- Department of Neurology, Unit of Cognitive Disorders, Hospital Universitario Donostia, San Sebastian, Spain
| | - Begoña Indakoetxea
- Department of Neurology, Unit of Cognitive Disorders, Hospital Universitario Donostia, San Sebastian, Spain
| | - Alberto Benussi
- Centre for Neurodegenerative Disorders, Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy
| | | | - Hernando Santamaria-Garcia
- School of Medicine, Neuroscience Doctorate. Aging Institute, Physiology and Psychiatry Department. Pontificia Universidad Javeriana, Bogotá, Colombia
| | - Diana Matallana
- School of Medicine, Neuroscience Doctorate. Aging Institute, Physiology and Psychiatry Department. Pontificia Universidad Javeriana, Bogotá, Colombia
| | | | - Anna Morozova
- Central Clinic No 1 of the Ministry of Internal Affairs, Moskva, Russia
| | - Olga Iakovleva
- Central Clinic No 1 of the Ministry of Internal Affairs, Moskva, Russia
| | - Nadezda Veryugina
- Central Clinic No 1 of the Ministry of Internal Affairs, Moskva, Russia
| | - Oleg Levin
- Central Clinic No 1 of the Ministry of Internal Affairs, Moskva, Russia
| | - Lina Zhao
- Innovation center for neurological disorders, Department of Neurology, Xuan Wu Hospital, Capital Medical University, 45 Changchun Street, Beijing
| | - Junhua Liang
- Innovation center for neurological disorders, Department of Neurology, Xuan Wu Hospital, Capital Medical University, 45 Changchun Street, Beijing
| | - Thomas Duning
- Clinic of Neurology with Institute for Translational Neurology, University Hospital Münster, Münster, Germany
| | - Thibaud Lebouvier
- Univ. Lille, Inserm, CHU Lille, U1172 - LilNCog - Lille Neuroscience & Cognition, LiCEND, F-59000 Lille, France
| | - Florence Pasquier
- Univ. Lille, Inserm, CHU Lille, U1172 - LilNCog - Lille Neuroscience & Cognition, LiCEND, F-59000 Lille, France
| | - David Huepe
- Center for Social and Cognitive Neuroscience, School of Psychology, Adolfo Ibáñez University, Santiago, Chile
| | - Myriam Barandiaran
- Department of Neurology, Unit of Cognitive Disorders, Hospital Universitario Donostia, San Sebastian, Spain
| | - Andreas Johnen
- Clinic of Neurology with Institute for Translational Neurology, University Hospital Münster, Münster, Germany
| | - Elena Lyashenko
- Central Clinic No 1 of the Ministry of Internal Affairs, Moskva, Russia
| | | | - Barbara Borroni
- Centre for Neurodegenerative Disorders, Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy
| | | | - Fen Wang
- Innovation center for neurological disorders, Department of Neurology, Xuan Wu Hospital, Capital Medical University, 45 Changchun Street, Beijing
| | - Monica Sanches Yassuda
- School of Arts, Sciences and Humanities, University of São Paulo, Department of Neurology, São Paulo, Brazil
| | | | | | | | - Carol Hudon
- Université Laval and CERVO Brain Research Centre, Québec, Canada
| | - Andrea Slachevsky
- Geroscience Center for Brain Health and Metabolism (GERO), Faculty of Medicine, University of Chile, Santiago, Chile
- Neuropsychology and Clinical Neuroscience Laboratory (LANNEC), Physiopathology Department - ICBM, Neurocience and East Neuroscience Departments, Faculty of Medicine, University of Chile, Santiago, Chile
- Memory and Neuropsychiatric Clinic (CMYN) Neurology Department, Hospital del Salvador and Faculty of Medicine, University of Chile, Santiago, Chile
- Servicio de Neurología, Departamento de Medicina, Clínica Alemana-Universidad del Desarrollo, Santiago, Chile
| | - Agustin Ibáñez
- Center for Social and Cognitive Neuroscience, School of Psychology, Adolfo Ibáñez University, Santiago, Chile
- Universidad de San Andrés, Buenos Aires, Argentina
- National Scientific and Technical Research Council (CONICET), Argentina
- Global Brain Health Institute (GBHI), University of California-San Francisco (UCSF), San Francisco, California, United States
- Universidad Autónoma del Caribe, Barranquilla, Colombia
| | - Michael Hornberger
- Norwich Medical School, University of East Anglia, UK
- Department of Clinical Neurosciences, University of Cambridge, UK
| | - Maxime Bertoux
- Univ. Lille, Inserm, CHU Lille, U1172 - LilNCog - Lille Neuroscience & Cognition, LiCEND, F-59000 Lille, France
- Department of Clinical Neurosciences, University of Cambridge, UK
| |
Collapse
|